Short Interest in CyberOptics Co. (NASDAQ:CYBE) Declines By 10.6%

Share on StockTwits

CyberOptics Co. (NASDAQ:CYBE) saw a significant drop in short interest during the month of July. As of July 31st, there was short interest totalling 216,600 shares, a drop of 10.6% from the June 30th total of 242,200 shares. Currently, 3.2% of the company’s stock are short sold. Based on an average daily volume of 47,800 shares, the short-interest ratio is presently 4.5 days.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Essex Investment Management Co. LLC lifted its position in CyberOptics by 17.0% in the 2nd quarter. Essex Investment Management Co. LLC now owns 117,934 shares of the scientific and technical instruments company’s stock worth $1,914,000 after buying an additional 17,108 shares during the last quarter. D. E. Shaw & Co. Inc. bought a new stake in CyberOptics in the 2nd quarter worth approximately $239,000. Marshall Wace LLP lifted its position in CyberOptics by 193.7% in the 2nd quarter. Marshall Wace LLP now owns 48,457 shares of the scientific and technical instruments company’s stock worth $786,000 after buying an additional 31,956 shares during the last quarter. BlackRock Inc. lifted its position in CyberOptics by 1.1% in the 2nd quarter. BlackRock Inc. now owns 208,736 shares of the scientific and technical instruments company’s stock worth $3,388,000 after buying an additional 2,295 shares during the last quarter. Finally, Acadian Asset Management LLC lifted its position in CyberOptics by 727.4% in the 2nd quarter. Acadian Asset Management LLC now owns 9,556 shares of the scientific and technical instruments company’s stock worth $156,000 after buying an additional 8,401 shares during the last quarter. Institutional investors and hedge funds own 60.48% of the company’s stock.

CYBE has been the topic of a number of recent analyst reports. Zacks Investment Research downgraded shares of CyberOptics from a “hold” rating to a “sell” rating in a report on Thursday, July 25th. TheStreet downgraded shares of CyberOptics from a “b-” rating to a “c+” rating in a report on Tuesday, May 28th. Lake Street Capital restated a “buy” rating and set a $18.00 target price (down from $25.00) on shares of CyberOptics in a report on Wednesday, July 3rd. Finally, ValuEngine upgraded shares of CyberOptics from a “sell” rating to a “hold” rating in a report on Thursday, August 1st.

CYBE traded up $0.10 during trading on Thursday, reaching $13.93. 60,131 shares of the stock were exchanged, compared to its average volume of 38,217. The stock has a market cap of $99.59 million, a P/E ratio of 35.72, a price-to-earnings-growth ratio of 38.75 and a beta of 0.30. CyberOptics has a twelve month low of $11.55 and a twelve month high of $22.61. The stock’s 50 day moving average price is $13.30 and its two-hundred day moving average price is $16.94. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.96 and a current ratio of 4.46.

CyberOptics (NASDAQ:CYBE) last issued its earnings results on Wednesday, July 24th. The scientific and technical instruments company reported $0.06 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.05) by $0.11. The business had revenue of $15.04 million for the quarter. CyberOptics had a net margin of 4.97% and a return on equity of 5.69%. Equities research analysts predict that CyberOptics will post 0.03 earnings per share for the current fiscal year.

CyberOptics Company Profile

CyberOptics Corporation develops and manufactures high precision sensing technology solutions worldwide. Its sensors are being used in surface mount technology (SMT), semiconductor, and metrology markets to improve yields and productivity. The company offers multi-reflection suppression sensors for application in the SMT, semiconductor, and metrology markets; and strobe inspection modules for use in 2D automated optical inspection (AOI) systems.

Recommended Story: Dividend Aristocrat Index

Receive News & Ratings for CyberOptics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CyberOptics and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.